Profund Advisors’s Nurix Therapeutics NRIX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $187K | Sell |
16,433
-6,754
| -29% | -$76.9K | 0.01% | 921 |
|
|
2025
Q1 | $275K | Buy |
23,187
+283
| +1% | +$3.36K | 0.01% | 722 |
|
|
2024
Q4 | $432K | Buy |
22,904
+3,866
| +20% | +$72.8K | 0.02% | 588 |
|
|
2024
Q3 | $428K | Sell |
19,038
-6,550
| -26% | -$147K | 0.02% | 597 |
|
|
2024
Q2 | $534K | Sell |
25,588
-7,472
| -23% | -$156K | 0.02% | 481 |
|
|
2024
Q1 | $486K | Buy |
+33,060
| New | +$486K | 0.02% | 586 |
|
|
2023
Q4 | – | Sell |
-17,233
| Closed | -$135K | – | 1147 |
|
|
2023
Q3 | $135K | Sell |
17,233
-4,016
| -19% | -$31.6K | 0.01% | 922 |
|
|
2023
Q2 | $212K | Sell |
21,249
-5,110
| -19% | -$51K | 0.01% | 941 |
|
|
2023
Q1 | $234K | Buy |
+26,359
| New | +$234K | 0.01% | 885 |
|